Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone in Diabetic Nephropathy
NCT00870402Phase 4Unknown
- Start
- Mar 2009
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of spironolactone in diabetic nephropathy (DN). Status: unknown.
02
Drugs
spironolactone
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT00870402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00870402.